Jakafi 15 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKJ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,583
Award facts
- Contract value 100% obligated
- $12,582.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,582.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of JAKAFI 15 mg. This firm fixed-price delivery order was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, and carries no set-aside designation. The award was issued without a set-aside, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. Performance will take place in Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with completion scheduled for December 31, 2036. The contract structure features a 30-month base period and three 30-month option periods, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier capable of fulfilling diverse and specialized medication requirements for the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKKJ9?
SPE2DR26FKKJ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FKKJ9 worth?
The government has obligated $12,583 on SPE2DR26FKKJ9.
Is contract SPE2DR26FKKJ9 an order under another contract?
Yes. SPE2DR26FKKJ9 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKJ9 competed?
The extent of competition for SPE2DR26FKKJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award